RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Vitaspring Biomedical Co. Stock

Vitaspring Biomedical Co. Liabilities 2025

Vitaspring Biomedical Co. Liabilities

2.03 M USD

Ticker

VSBC

ISIN

US92851B1026

In 2025, Vitaspring Biomedical Co.'s total liabilities amounted to 2.03 M USD, a 0% difference from the 0 USD total liabilities in the previous year.

Vitaspring Biomedical Co. Aktienanalyse

What does Vitaspring Biomedical Co. do?

Vitaspring Biomedical Co. Ltd is a leading biomedical research and development company founded in Shanghai, China in 2001. The company specializes in the manufacturing and marketing of innovative medical technologies, biocomponents, and related services. It has become a significant partner and supplier for both domestic and international customers due to the high quality and reliability of its products and services. The company's unique business model is based on environmental and health topics, focusing on the areas of life sciences and biotechnology. Vitaspring Biomedical aims to develop products and services that can provide real benefits to humanity based on medical and scientific foundations. The hope is that all the company's future products and services will contribute to sustainably improving the quality of people's lives worldwide. Vitaspring Biomedical was founded by Dr. Yanfeng Bi in Shanghai, who is also the current CEO of the company. Dr. Bi has a strong background in biomedicine, psychology, and immunology. He emphasizes the importance of understanding people's needs and finding solutions that can truly make a difference. The company is divided into two main divisions: Life Science and Medical Equipment. The Life Science division consists of two subgroups: a) Biocomponents: This subgroup includes products related to biochemistry, molecular biology, and immunology. Vitaspring Biomedical produces a variety of biological reagents such as antibodies, proteins, enzymes, and allelotyping systems for scientific research laboratories. The products in this group have a wide range of applications in basic research, drug development, food control, and clinical diagnosis. b) Biomedical services: These services include customized and specialized services for life science research institutions and companies. This includes biostatistics, data management, bioinformatics, cell therapy services, and human experiment monitoring services. The Medical Equipment division offers equipment solutions for research, clinical diagnosis, and therapy. The products in this division include specialized facilities for clinical research and diagnosis, skincare devices, and endoscopy equipment. Vitaspring Biomedical's product portfolio mainly consists of specialized and customized applications for laboratory equipment, diagnostic equipment, and consumables for professional users. Some of the key products include antibodies, proteins, blood glucose meters, endoscopy devices, and skincare products. Overall, Vitaspring Biomedical Co. Ltd is a reputable company in the biomedical industry based in Shanghai, China. It focuses on researching, developing, and manufacturing innovative and high-quality products and services in the field of life sciences and medical technology. The company's various divisions include biocomponents, biomedical services, and medical equipment. Its extensive product range includes antibodies, proteins, blood glucose meters, endoscopy devices, and skincare products. Vitaspring Biomedical Co. ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Vitaspring Biomedical Co.'s Liabilities

Vitaspring Biomedical Co.'s liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Vitaspring Biomedical Co.'s financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Vitaspring Biomedical Co.'s liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Vitaspring Biomedical Co.'s total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Vitaspring Biomedical Co.’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Vitaspring Biomedical Co. stock

What is the level of liabilities of Vitaspring Biomedical Co. this year?

Vitaspring Biomedical Co. has a debt balance of 2.03 M USD this year.

What were the liabilities of Vitaspring Biomedical Co. compared to the previous year?

The liabilities of Vitaspring Biomedical Co. have increased by 0% dropped compared to the previous year.

What are the consequences of high debt for investors of Vitaspring Biomedical Co.?

High liabilities can pose a risk for investors of Vitaspring Biomedical Co., as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Vitaspring Biomedical Co.?

Low liabilities mean that Vitaspring Biomedical Co. has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Vitaspring Biomedical Co. affect the company?

An increase in liabilities of Vitaspring Biomedical Co. can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Vitaspring Biomedical Co. affect the company?

A decrease in the liabilities of Vitaspring Biomedical Co. can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Vitaspring Biomedical Co.?

Some factors that can influence the liabilities of Vitaspring Biomedical Co. include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Vitaspring Biomedical Co. so important for investors?

The liabilities of Vitaspring Biomedical Co. are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Vitaspring Biomedical Co. take to modify the liabilities?

To change its liabilities, Vitaspring Biomedical Co. can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Vitaspring Biomedical Co. pay?

Over the past 12 months, Vitaspring Biomedical Co. paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Vitaspring Biomedical Co. is expected to pay a dividend of 0 USD.

What is the dividend yield of Vitaspring Biomedical Co.?

The current dividend yield of Vitaspring Biomedical Co. is .

When does Vitaspring Biomedical Co. pay dividends?

Vitaspring Biomedical Co. pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Vitaspring Biomedical Co.?

Vitaspring Biomedical Co. paid dividends every year for the past 0 years.

What is the dividend of Vitaspring Biomedical Co.?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Vitaspring Biomedical Co. located?

Vitaspring Biomedical Co. is assigned to the '-' sector.

Wann musste ich die Aktien von Vitaspring Biomedical Co. kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vitaspring Biomedical Co. from 9/7/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/7/2025.

When did Vitaspring Biomedical Co. pay the last dividend?

The last dividend was paid out on 9/7/2025.

What was the dividend of Vitaspring Biomedical Co. in the year 2024?

In the year 2024, Vitaspring Biomedical Co. distributed 0 USD as dividends.

In which currency does Vitaspring Biomedical Co. pay out the dividend?

The dividends of Vitaspring Biomedical Co. are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Vitaspring Biomedical Co.

Our stock analysis for Vitaspring Biomedical Co. Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vitaspring Biomedical Co. Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.